The company said it couldn't disclose details about the safety issue that prompted the company to halt its trials.
The company said it couldn't disclose details about the safety issue that prompted the company to halt its trials.
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться